Strong associations emerged between mutations in ESR1, GATA3, and PIK3CA in metastatic tumors, particularly ESR1 mutations at positions 380, 536, 537, and 538 pairing with PIK3CA mutations at positions 542, 545, and 1047 (Fig 6B). Here, PIK3CA is linked to metastatic neoplasm.